City

Boston (1)

Stanford (1)

Condition

Allogeneic Hematopoietic Cell Transplantation (HCT) (2)

Acute Leukemia (1)

Advanced Hematologic Malignancies (1)

Chronic Myelogenous Leukemia (1)

Myelodysplastic Syndromes (1)

Myeloproliferative Disorders (1)

Overall Status

Recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Stanford University (1)

Zachariah Michael DeFilipp (1)

Collaborator

Orca Biosystems, Inc. (1)

Study Documents

Intervention Type

drug (2)

device (1)

Funder Type

Other (2)

Study Type

Interventional (2)

allogeneic hematopoietic cell transplantation (hct)

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Allogeneic Hematopoietic Cell Transplantation (HCT) Trial in Boston (FMT, Placebo)

Terminated

Has Results

Allogeneic Hematopoietic Cell Transplantation (HCT)

FMT
Placebo

Boston, Massachusetts

Massachusetts General Hospital Cancer Center

Nov 3, 2021

Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia Trial in Stanford

Recruiting

Allogeneic Hematopoietic Cell Transplantation (HCT)
+5 more

Purified regulatory T-cells (Treg) plus CD34+ HSPC
+7 more

Stanford, California

Stanford University

Oct 28, 2021